Key Events This Week
Mar 30: Stock closes at Rs.61.97, down 1.01%
Apr 1: Stock declines further to Rs.61.00 (-1.57%)
Apr 2: New 52-week low of Rs.58.1 recorded amid volatility
Apr 2: Rating upgraded to 'Sell' by MarketsMOJO

Sunil Healthcare Ltd Falls to 52-Week Low of Rs 58.1 as Sell-Off Deepens
2026-04-02 14:10:07For the fourth consecutive session, Sunil Healthcare Ltd closed lower, culminating in a fresh 52-week low of Rs 58.1 on 2 Apr 2026. This decline comes despite an intraday high of Rs 64.5, reflecting significant volatility and persistent selling pressure.
Read full news article
Sunil Healthcare Ltd Rating Upgraded to Sell on Valuation and Financial Trends
2026-04-02 08:11:23Sunil Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced improvement in valuation metrics and financial trends, despite ongoing challenges in quality and technical indicators. The company’s Mojo Score now stands at 32.0, signalling a cautious but more favourable outlook compared to its previous standing.
Read full news articleSunil Healthcare Ltd Declines 1.94% Amid Valuation Upgrade and Persistent Downtrend
2026-03-29 11:00:55
Key Events This Week
16 Mar: Stock hits 52-week low of Rs.60.66 amid sharp decline
17 Mar: Further 52-week low at Rs.58.61 despite intraday highs
19 Mar: Rating upgraded to Sell; stock closes at Rs.61.95
20 Mar: Stock rebounds to Rs.63.25, ending week with slight loss

Sunil Healthcare Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals
2026-03-24 08:15:33Sunil Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 March 2026, reflecting a complex interplay of valuation improvements, financial trends, quality concerns and technical indicators. Despite some positive quarterly results and an attractive valuation profile, the company’s weak long-term fundamentals and underperformance relative to the broader market have weighed heavily on investor sentiment.
Read full news article
Sunil Healthcare Ltd Falls to 52-Week Low of Rs.58.4 Amid Market Volatility
2026-03-19 12:10:13Sunil Healthcare Ltd’s stock declined sharply to a fresh 52-week low of Rs.58.4 today, marking a significant downturn amid a volatile trading session and broader market pressures. The stock’s performance contrasts with the modest recovery seen in the Sensex, underscoring sector-specific and company-level challenges.
Read full news article
Sunil Healthcare Ltd Upgraded to Sell on Improved Valuation and Financial Trends
2026-03-19 08:06:42Sunil Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Mar 2026, driven primarily by a marked improvement in valuation metrics and positive financial trends. Despite lingering concerns over long-term fundamentals and market underperformance, the company’s very attractive valuation and recent quarterly results have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2026 | Source : BSECompliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026
Closure of Trading Window
27-Mar-2026 | Source : BSEIntimation of Closure of Trading Window for the declaration of audited financial results for the 4th quarter/ financial year ended 31.03.2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
08-Feb-2026 | Source : BSENewspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available








